•Executive Summary o Market Overview •Market Landscape o Market ecosystem o Value chain analysis •Market Sizing o Market definition o Market segment analysis o Market size 2019 o Market outlook: Forecast for 2019 - 2024 •Five Forces Analysis o Bargaining power of buyers o Bargaining power of suppliers o Threat of new entrants o Threat of substitutes o Threat of rivalry o Market condition •Market Segmentation by Application o Market segments o Comparison by Application o Surgical wound care - Market size and forecast 2019-2024 o Traditional wound care - Market size and forecast 2019-2024 o Market opportunity by Application •Customer landscape o Overview •Geographic Landscape o Geographic segmentation o Geographic comparison o North America - Market size and forecast 2019-2024 o Europe - Market size and forecast 2019-2024 o APAC - Market size and forecast 2019-2024 o South America - Market size and forecast 2019-2024 o MEA - Market size and forecast 2019-2024 o Key leading countries o Market opportunity by geography •Drivers, Challenges, and Trends o Market drivers o Volume driver - Demand led growth o Volume driver - Supply led growth o Volume driver - External factors o Volume driver - Demand shift in adjacent markets o Price driver - Inflation o Price driver - Shift from lower to higher-priced units o Market challenges o Market trends •Vendor Landscape o Overview o Landscape disruption •Vendor Analysis o Vendors covered o Market positioning of vendors o 3M Co. o B. Braun Melsungen AG o Biogenesis Bago SA o Ceva Sante Animale o Indian Immunologicals Ltd. o Johnson & Johnson o Medtronic Plc o Phibro Animal Health Corp. o Vetoquinol SA o Virbac Group •Appendix o Scope of the report o Currency conversion rates for US$ o Research methodology o List of abbreviations •1.Key Finding 1 •2.Key Finding 2 •3.Key Finding 3 •4.Key Finding 5 •5.Key Finding 6 •6.Key Finding 7 •7.Key Finding 8 •8.Market in focus •10.Parent market •13.Market characteristics •15.Offerings of vendors included in the market definition •17.Market segments •22.Global - Market size and forecast 2019 - 2024 ($ million) •23.Global market: Year-over-year growth 2019 - 2024 (%) •24.Five forces analysis 2019 & 2024 •26.Bargaining power of buyers •27.Bargaining power of suppliers •28.Threat of new entrants •29.Threat of substitutes •30.Threat of rivalry •32.Market condition - Five forces 2019 •34.Application placement - Market share 2019-2024 (%) •35.Comparison by Application •38.Surgical wound care - Market size and forecast 2019-2024 ($ million) •39.Surgical wound care - Year-over-year growth 2019-2024 (%) •42.Traditional wound care - Market size and forecast 2019-2024 ($ million) •43.Traditional wound care - Year-over-year growth 2019-2024 (%) •44. Market opportunity by Application •45.Customer landscape •47.Market share by geography 2019-2024 (%) •48.Geographic comparison •51.North America - Market size and forecast 2019-2024 ($ million) •53.North America - Year-over-year growth 2019-2024 (%) •56.Europe - Market size and forecast 2019-2024 ($ million) •58.Europe - Year-over-year growth 2019-2024 (%) •61.APAC - Market size and forecast 2019-2024 ($ million) •63.APAC - Year-over-year growth 2019-2024 (%) •66.South America - Market size and forecast 2019-2024 ($ million) •68.South America - Year-over-year growth 2019-2024 (%) •71.MEA - Market size and forecast 2019-2024 ($ million) •73.MEA - Year-over-year growth 2019-2024 (%) •75.Key leading countries •77.Market opportunity by geography ($ million) •78.Impact of drivers and challenges •79.Vendor landscape •81.Landscape disruption •83.Industry risks •85.Vendors covered •87.Market positioning of vendors •89.3M Co. - Overview •90.3M Co. - Business segments •91.3M Co. - Key offerings •92.3M Co. - Key customers •93.3M Co. - Segment focus •95.B. Braun Melsungen AG - Overview •96.B. Braun Melsungen AG - Business segments •97.B. Braun Melsungen AG - Key offerings •98.B. Braun Melsungen AG - Key customers •99.B. Braun Melsungen AG - Segment focus •101.Biogenesis Bago SA - Overview •102.Biogenesis Bago SA - Product and service •103.Biogenesis Bago SA - Key offerings •104.Biogenesis Bago SA - Key customers •105.Biogenesis Bago SA - Segment focus •107.Ceva Sante Animale - Overview •108.Ceva Sante Animale - Product and service •109.Ceva Sante Animale - Key offerings •110.Ceva Sante Animale - Key customers •111.Ceva Sante Animale - Segment focus •113.Indian Immunologicals Ltd. - Overview •114.Indian Immunologicals Ltd. - Product and service •115.Indian Immunologicals Ltd. - Key offerings •116.Indian Immunologicals Ltd. - Key customers •117.Indian Immunologicals Ltd. - Segment focus •119.Johnson & Johnson - Overview •120.Johnson & Johnson - Business segments •121.Johnson & Johnson - Key offerings •122.Johnson & Johnson - Key customers •123.Johnson & Johnson - Segment focus •125.Medtronic Plc - Overview •126.Medtronic Plc - Business segments •127.Medtronic Plc - Key offerings •128.Medtronic Plc - Key customers •129.Medtronic Plc - Segment focus •130. •131.Phibro Animal Health Corp. - Overview •132.Phibro Animal Health Corp. - Business segments •133.Phibro Animal Health Corp. - Key offerings •134.Phibro Animal Health Corp. - Key customers •135.Phibro Animal Health Corp. - Segment focus •137.Vetoquinol SA - Overview •138.Vetoquinol SA - Business segments •139.Vetoquinol SA - Key offerings •140.Vetoquinol SA - Key customers •141.Vetoquinol SA - Segment focus •143.Virbac Group - Overview •144.Virbac Group - Business segments •145.Virbac Group - Key offerings •146.Virbac Group - Key customers •147.Virbac Group - Segment focus •149.Currency conversion rates for US$ •150.Research Methodology •151.Validation techniques employed for market sizing •152.Information sources •153. List of abbreviations

3M Co., B. Braun Melsungen AG, Biogenesis Bago SA, Ceva Sante Animale, Indian Immunologicals Ltd., Johnson & Johnson, Medtronic Plc, Phibro Animal Health Corp., Vetoquinol SA, Virbac Group